Showing 7 of 107 recruiting trials for “acute-leukemia-of-ambiguous-lineage”
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
Familial Investigations of Childhood Cancer Predisposition
👨⚕️ Kim E. Nichols, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Apr 2017View details ↗
RecruitingNCT03275480 ↗
Institut Paoli Calmettes Myelodysplastic Syndromes Database
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
RecruitingNCT01311258 ↗
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
RecruitingNCT01890486 ↗
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
👨⚕️ Dianna Howard, MD, Wake Forest University Health Sciences📍 1 site📅 Started May 2001View details ↗
← PreviousPage 6 of 6
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →